Charles Crawley

Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge CB10 1SA, UK; Department of Haematology, Cambridge Biomedical Campus, University of Cambridge, Cambridge CB2 0XY, UK; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, UK. Electronic address:

View Article and Find Full Text PDF

March 2015

Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol.

Authors:

Niccolò Bolli Nicla Manes Thomas McKerrell Jianxiang Chi Naomi Park Gunes Gundem Michael A Quail Vijitha Sathiaseelan Bram Herman Charles Crawley Jenny I O Craig Natalie Conte Carolyn Grove Elli Papaemmanuil Peter J Campbell Ignacio Varela Paul Costeas George S Vassiliou

Haematologica 2015 Feb 7;100(2):214-22. Epub 2014 Nov 7.

Haematological Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, UK

View Article and Find Full Text PDF

February 2015

A case of bilateral ureteric obstruction in an allogeneic stem cell transplant recipient.

Authors:

Stephen P Smith Charles R Crawley Teik C See Nicholas J Screaton Jacobus M Preller

J Clin Virol 2013 Jan 25;56(1):1-4. Epub 2012 Jul 25.

Addenbrookes Hospital, Cambridge CB2 0QQ, United Kingdom.

View Article and Find Full Text PDF

January 2013

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.

Authors:

Peter Connick Madhan Kolappan Charles Crawley Daniel J Webber Rickie Patani Andrew W Michell Ming-Qing Du Shi-Lu Luan Daniel R Altmann Alan J Thompson Alastair Compston Michael A Scott David H Miller Siddharthan Chandran

Lancet Neurol 2012 Feb 10;11(2):150-6. Epub 2012 Jan 10.

Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

View Article and Find Full Text PDF

February 2012

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).

Blood 2012 Apr 10;119(14):3361-9. Epub 2012 Jan 10.

School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom;

View Article and Find Full Text PDF

April 2012

High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.

Authors:

Nicolas Mounier Carmen Canals Christian Gisselbrecht Jan Cornelissen Roberto Foa Eulogio Conde John Maertens Michel Attal Alessandro Rambaldi Charles Crawley Jian-Jian Luan Mats Brune Sebastian Wittnebel Gordon Cook G W van Imhoff Michael Pfreundschuh Anna Sureda

Biol Blood Marrow Transplant 2012 May 17;18(5):788-93. Epub 2011 Oct 17.

CHU de l'Archet, Nice, France.

View Article and Find Full Text PDF

May 2012

Bilateral irreversible blindness in leukaemic meningitis: cause or cure?

Authors:

Christos Tziotzios George Follows Nicholas Sarkies Charles Crawley

Ann Hematol 2011 Dec 4;90(12):1487-8. Epub 2011 Mar 4.

View Article and Find Full Text PDF

December 2011

The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments.

Trials 2011 Mar 2;12:62. Epub 2011 Mar 2.

Dept, of Clinical Neurosciences, University of Cambridge, UK.

View Article and Find Full Text PDF

March 2011

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.

Blood 2010 Oct 29;116(16):3080-8. Epub 2010 Jun 29.

Royal Free Hampstead National Health Service (NHS) Trust, London, United Kingdom.

View Article and Find Full Text PDF

October 2010

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

Authors:

André Tichelli Jakob Passweg Dorota Wójcik Alicia Rovó Jean-Luc Harousseau Tamas Masszi Axel Zander Albert Békássy Charles Crawley Mutlu Arat Simona Sica Patrick Lutz Gérard Socié

Haematologica 2008 Aug 12;93(8):1203-10. Epub 2008 Jun 12.

Department of Hematology, University Hospital, CH 4031-Basel, Switzerland.

View Article and Find Full Text PDF

August 2008

Complete molecular responses are achieved after reduced intensity stem cell transplantation and donor lymphocyte infusion in chronic myeloid leukemia.

Authors:

Nicholas B Heaney Mhairi Copland Karen Stewart Judith Godden Anne N Parker I Grant McQuaker Graeme M Smith Charles Crawley Pat Shepherd Tessa L Holyoake

Blood 2008 May 31;111(10):5252-5. Epub 2008 Mar 31.

Section of Experimental Haematology and Haemopoietic Stem Cells, University of Glasgow, Glasgow, USA.

View Article and Find Full Text PDF

May 2008

Invasive fungal sinusitis in patients treated with fludarabine.

Authors:

Tony Todd Martin Besser Emma Gudgin Charles Crawley Jenny I O Craig George Follows Robert E Marcus David A Enoch James S Cargill Hugo A Ludlam Sandra Young Min Pat Sartori

J Infect 2008 Feb 26;56(2):156-8. Epub 2007 Dec 26.

View Article and Find Full Text PDF

February 2008

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.

Authors:

Gösta Gahrton Simona Iacobelli Giuseppe Bandini Bo Björkstrand Paolo Corradini Charles Crawley Ute Hegenbart Gareth Morgan Nicolaus Kröger Anton Schattenberg Stefan O Schönland Leo F Verdonck Lisa Volin Theo de Witte Dietger Niederwieser

Haematologica 2007 Nov;92(11):1513-8

Department of Medicine, Karolinska institutet, Karolinska University Hospital, Huddinge, SE 14186 Stockholm, Sweden.

View Article and Find Full Text PDF

November 2007

Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning.

Authors:

Charles Crawley Simona Iacobelli Bo Björkstrand Jane F Apperley Dietger Niederwieser Gösta Gahrton

Blood 2007 Apr 7;109(8):3588-94. Epub 2006 Dec 7.

Department of Haematology, Addenbrooke's Hospital, Hills Road, Cambridge, UK.

View Article and Find Full Text PDF

April 2007

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Authors:

Alois Gratwohl Ronald Brand Jane Apperley Charles Crawley Tapani Ruutu Paolo Corradini Enric Carreras Agnes Devergie Cesare Guglielmi Hans-Jochen Kolb Dietger Niederwieser

Haematologica 2006 Apr 1;91(4):513-21. Epub 2006 Mar 1.

Hematology, University Hospital Basel, Switzerland.

View Article and Find Full Text PDF

April 2006

The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.

Authors:

Gordon Cook Richard E Clark Charles Crawley Stephen Mackinnon Nigel Russell Kirsty Thomson Rachel M Pearce Keiren Towlson David I Marks

Biol Blood Marrow Transplant 2006 Mar;12(3):293-300

St. James' Hospital, Leeds, and Royal Liverpool University Hospital, United Kingdom.

View Article and Find Full Text PDF

March 2006

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers.

Authors:

Mark Cobbold Naeem Khan Batoul Pourgheysari Sudhir Tauro Dorothy McDonald Husam Osman Mario Assenmacher Lucinda Billingham Colin Steward Charles Crawley Eduardo Olavarria John Goldman Ronjon Chakraverty Premini Mahendra Charles Craddock Paul A H Moss

J Exp Med 2005 Aug;202(3):379-86

Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TT, England, UK.

View Article and Find Full Text PDF

August 2005

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

Blood 2005 Nov 5;106(9):2969-76. Epub 2005 Jul 5.

Clinical Haematology, Box 234, Addenbrookes Hospital, Cambridge, CB2 2QQ United Kingdom.

View Article and Find Full Text PDF

November 2005

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

Blood 2005 Jun 24;105(11):4532-9. Epub 2005 Feb 24.

Clinical Haematology, Box 234, Addenbrookes Hospital, Cambridge, CB2 2QQ, United Kingdom.

View Article and Find Full Text PDF

June 2005

Publications by authors named "Charles Crawley"

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors: